First Long Island Investors, LLC Biogen Inc. Transaction History

First Long Island Investors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 01, 2021	SELL	$282.99 - $369.05 $224,411 - $292,656	-793 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$242.95 - $284.63 $192,659 - $225,711	793 New	793 $222,000
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $187,354 - $282,014	-793 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $9,311 - $12,331	-36 Reduced 4.34%	793 $212,000
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $182,429 - $252,074	829 New	829 $246,000
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $180,086 - $281,675	-831 Closed	0 $0
Q1 2018 May 04, 2018	SELL	$260.13 - $367.91 $1,300 - $1,839	-5 Reduced 0.6%	831 $228,000
Q4 2017 Feb 07, 2018	BUY	$307.64 - $344.58 $1,538 - $1,722	5 Added 0.6%	836 $266,000
Q2 2017 Aug 14, 2017	BUY	N/A	831	831 $0

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of First Long Island Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on First Long Island Investors, LLC with notifications on news.